- Report
- September 2021
- 232 Pages
Global
From €5872EUR$6,168USD£5,020GBP
- Report
- May 2021
- 307 Pages
Global
From €5872EUR$6,168USD£5,020GBP
- Report
- December 2020
- 262 Pages
Global
From €5969EUR$6,269USD£5,102GBP
- Report
- January 2024
- 150 Pages
United States
From €5712EUR$5,999USD£4,882GBP
- Report
- November 2023
- 175 Pages
Global
From €2665EUR$2,799USD£2,278GBP
- Report
- May 2023
- 147 Pages
Global
From €5712EUR$5,999USD£4,882GBP
- Report
- May 2023
- 147 Pages
Global
From €5712EUR$5,999USD£4,882GBP
The Dialysate market is a segment of the dialysis industry that focuses on the production and distribution of dialysate, a solution used in hemodialysis to remove toxins from the blood. Dialysate is typically composed of electrolytes, bicarbonate, and other components that are tailored to the patient's needs. Dialysate is typically delivered to dialysis centers in pre-mixed bags or concentrates, and is then diluted and used in the dialysis machine.
The dialysate market is highly competitive, with a number of companies offering products and services. Major players in the market include Fresenius Medical Care, Baxter International, B. Braun Melsungen AG, Nipro Corporation, and Nikkiso Co. Ltd. Other companies in the market include Diaverum, DiaMedica, and DiaSorin. Show Less Read more